Supported by Vance Street Capital, PDC has finalized its acquisition of Resenex—a deal that will help the company advance fluid management solutions amongst its customers. 

Neither company disclosed the transaction’s terms.

“We are delighted to welcome Resenex to the PDC family,” PDC CEO Jeff Kyle said. “This acquisition aligns perfectly with our commitment to innovation and excellence across diverse health, science, and technology markets. By combining PDC’s expertise in precision injection molding, in-house tool design and build, and value-added assembly with Resenex’s product portfolio, we will further enhance our ability to provide solutions to our customers and accelerate growth in adjacent markets.”
 
“PDC’s strong commitment to quality, innovation, and customer service aligns perfectly with the values that have guided Resenex since its founding. “This acquisition will allow Resenex’s products and capabilities to reach new heights, and I look forward to seeing continued growth and success,” former Chief Operating Officer Shefali Parikh stated.
 
“We are thrilled to support PDC in this strategic acquisition,” added Vance Street Capital Partner Steve Sandbo. “Resenex has a strong reputation for quality and innovation in fluid flow products, which will enhance PDC’s capabilities and expand its product offerings. By merging Resenex’s product line with PDC’s expertise in injection molding, we are poised to respond quickly to the evolving market demands and drive growth in new areas. This partnership creates significant expansion opportunities and reinforces PDC’s position as a leading provider of advanced micro molding manufacturing solutions across healthcare and biotechnology markets.”
 
Resenex was founded in 1981 by Pradip Choksi as an OEM of plastic fluid flow products, including check valves, including adjustable pressure relief valves, shielded connectors, and standard and tethered caps for medical and industrial applications. Resenex provides high-flow check valves and shielded connectors with tubing socket and barbed connectors for medical applications, including biopharmaceutical, infusion, wound care, surgical, and in-vitro diagnostics. The portfolio of products consists of off-the-shelf solutions using patented technology and customized products for more unique configurations. Resenex was founded in Chatsworth, Calif., and moved to Scottsdale, Ariz., in July 2024. 
 
PDC is a contract manufacturer specializing in precision injection molding and value-added assembly for the medical device and life science markets. For more than 30 years, PDC has brought extensive expertise in working with complex materials like PEEK, COP, and COC. With a continued dedication to delivering products that meet stringent ISO 13485:2016 quality system standards, PDC’s focus on innovation, customer service, and advanced technology makes the firm an ideal micro molding partner. PDC is part of the Vance Street Capital portfolio.
 
Vance Street Capital LLC is a middle-market private equity firm investing in highly engineered solutions businesses across the medical, aerospace, defense, and industrial sectors. Vance Street’s partners have worked with management teams and family owners for more than two decades to accelerate revenue growth, improve operations, and acquire strategic assets for the companies in its investment portfolio.